Patent · US Active

Therapeutic agent

US8173694B2 · kind B2 · utility

2Cited by
7References
17Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 16, 2009
Grant dateMay 8, 2012
Priority date
Expiry dateJun 4, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are agents and methods for use in depleting serum amyloid P component (SAP) from a patient in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.